These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22017012)

  • 1. [Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].
    Zhai YJ; Guo CY; Hou JN; Zhang WD; Zhai GX
    Zhong Yao Cai; 2011 Jun; 34(6):962-5. PubMed ID: 22017012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
    Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
    Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on preparation of quercetin nanostructured lipid carriers and their physicochemical properties].
    Yu L; Yang JR; Liu Y; Zhou T; Kuang YM; Lu SS; Zhang TY; Guo Y
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1151-5. PubMed ID: 23944027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
    Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
    Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on preparation and characterization of resveratrol solid lipid nanoparticles and its anticancer effects in vitro].
    Zhang QH; Xiong QP; Shi YY; Zhang DY
    Zhong Yao Cai; 2010 Dec; 33(12):1929-32. PubMed ID: 21548373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
    Tsai MJ; Wu PC; Huang YB; Chang JS; Lin CL; Tsai YH; Fang JY
    Int J Pharm; 2012 Feb; 423(2):461-70. PubMed ID: 22193056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration.
    Zhao C; Liu Y; Fan T; Zhou D; Yang Y; Jin Y; Zhang Z; Huang Y
    Pharm Dev Technol; 2012; 17(4):443-56. PubMed ID: 21222507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers as a delivery system of biochanin A.
    Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
    Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
    Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y
    Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and physiochemical properties of curcumin-loaded lipid cubic liquid crystalline nanoparticles].
    Su X; He XL; Liu XJ; Guo JY; Zhai GX
    Zhong Yao Cai; 2012 Feb; 35(2):296-9. PubMed ID: 22822677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation and characterization of solid lipid nanoparticles of norcantharidin].
    Tian HY; Zhai GX
    Zhong Yao Cai; 2007 Sep; 30(9):1146-8. PubMed ID: 18236763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.